Latest Medicine stories from Life.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development.
Strategic angle: A medieval ophthalmologist who translated Greek works by Galen, Hippocrates, and Plato into Arabic played a pivotal role in shaping Western medical scholarship, according to a study published in the journal Cogent Arts a
Strategic angle: Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.
Strategic angle: Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, extending survival in preclinical models.
Strategic angle: A bill is moving through the Colorado legislature that would exempt orphan drugs from pricing caps that might be pursued by the state.
Strategic angle: The war in Iran has slowed down international shipping, much of which contains medical and humanitarian goods destined for Asia and Africa.
Strategic angle: Innovative blood-catalyzed chemistry paves the way for advanced medical applications.
Strategic angle: A reactivation of the virus that causes chickenpox, the illness can be miserable. Here's what to know about early warning signs, long-term symptoms and some surprising news about the vaccine.
France's foreign ministry expresses consternation over the execution of a French citizen sentenced to death in China.
Strategic angle: Smaller biotechs negotiate with the White House while addressing the trust gap in medicine.
Strategic angle: “The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
Strategic angle: A Supreme Court ruling this week on gender and sexuality 'conversion therapy' could narrow the authority of state medical boards over care involving speech.
Strategic angle: A new way to define obesity aims to sharpen the diagnosis. Critics warn it could delay care, exclude diabetes, and deepen inequities in accessing treatment.
Strategic angle: The daily pill called Foundayo got a fast track through the Food and Drug Administration.
Strategic angle: A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
Strategic angle: A new study explores whether incorporating psychotherapy with ketamine treatment enhances its effectiveness.
Strategic angle: “Rigorously derived evidence for the medical efficacy of marijuana is thin,” writes Kevin Sabet.